Small Molecule CDMO Market Fueled by Increasing R&D in Emerging Markets
According to a recent study by Grand View Research, Inc., the global small molecule CDMO (Contract Development and Manufacturing Organization) market is projected to reach USD 108.46 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. Key factors driving this growth include the adoption of innovative technologies in small molecule drug development, the expansion of pharmaceutical pipelines focused on small molecule therapies, and the increasing reliance on CDMOs for their cost-efficiency and specialized services. Regulatory support for streamlined drug development and manufacturing processes, along with CDMOs scaling up their production capacities to meet growing industry needs, also contribute significantly to market expansion. For pharmaceutical companies, innovation and ease of access to clinical solutions remain essential. Specialty pharmaceutical firms and small-scale players are playing a pivotal role in meeting these cr...